Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers - ASCO | Cliniscan
Cliniscan
Solutions
Tarifs
Ressources
Se connecter
Essayer gratuitement
Cliniscan
Retour aux recommandations
ASCO
2023
·
USA
·
Oncology
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers
Document
Analyser ce document
